Boehringer Ingelheim: all 2,305 studies
Page 8 of 24. Open to participants first (62), then studies with results posted, then the rest; newest registration first within each.
- Linagliptin Among Filipino Patients With Type 2 Diabetes MellitusTerminatedNCT01826370Results posted
- Pharmacokinetics of Faldaprevir of Soft CapsuleCompletedNCT01821937Phase 1Results posted
- ADAM-Afatinib Diarrhea Assessment and ManagementCompletedNCT01814553Phase 3Results posted
- Equivalence of Resorption of Empagliflozin/Metformin Administered as Combination Tablet Compared With Empagliflozin/Metformin as Single Tablets Administered TogetherCompletedNCT01811953Phase 1Results posted
- Preference Tiotropium Respimat Study in COPDCompletedNCT01810692Results posted
- Single Dose Ranging Study of BI 1744 CL (Olodaterol) in Chronic Obstructive Pulmonary DiseaseCompletedNCT01809262Phase 2Results posted
- Investigation of Interactions Between Faldaprevir, Itraconazole, Atorvastatin and RosuvastatinCompletedNCT01795937Phase 1Results posted
- MARLINA - T2D : Efficacy, Safety & Modification of Albuminuria in Type 2 Diabetes Subjects With Renal Disease With LINAgliptinCompletedNCT01792518Phase 3Results posted
- Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male SubjectsCompletedNCT01787032Phase 1Results posted
- Investigation of Faldaprevir Effect on Pharmacokinetics of RaltegravirCompletedNCT01785160Phase 1Results posted
- Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 DiabetesCompletedNCT01778049Phase 3Results posted
- SPARK: Safety Study of Pradaxa in Atrial Fibrillation Patients by Regulatory Requirement of KoreaCompletedNCT01774370Results posted
- Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various TumoursCompletedNCT01772563Phase 1Results posted
- Relative Bioavailability of a Single Dose of Nintedanib Given Alone and in Combination With Multiple Doses of RifampicinCompletedNCT01770392Phase 1Results posted
- Relative Bioavailability of BI 201335 Capsule Versus Three Different Oral SolutionsCompletedNCT01764945Phase 1Results posted
- To Investigate the Safety, Tolerability, Pharmacokinetics and the Relative Bioavailability of BI 1026706CompletedNCT01763333Phase 1Results posted
- Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Clinical Effects of Multiple Rising Subcutaneous Doses of BI 655064 in Healthy Volunteers and in Rheumatoid Arthritis Patients With Prior Inadequate Response to Methotrexate TherapyCompletedNCT01751776Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of Different Multiple Doses of BI 207127 BID and Multiple Doses of BI 207127 Combined With Faldaprevir in Healthy Male and Female SubjectsCompletedNCT01737996Phase 1Results posted
- Relative Bioavailability Study to Investigate and to Compare Two Different Formulations of Hyoscine Butylbromide in Healthy Male and Female VolunteersCompletedNCT01734902Phase 1Results posted
- Safety and Efficacy of the Combination of Empagliflozin and Linagliptin Compared to Linagliptin Alone Over 24 Weeks in Patients With Type 2 DiabetesCompletedNCT01734785Phase 3Results posted
- Investigation of Drug-drug Interaction of Dabigatran and TicagrelorCompletedNCT01734772Phase 1Results posted
- IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1CompletedNCT01732796Phase 3Results posted
- Phase 3 Study of BI 207127 in Combination With Faldaprevir and Ribavirin for Treatment of Patients With Hepatitis C Infection, Including Patients Who Are Not Eligible to Receive Peginterferon: HCVerso2CompletedNCT01728324Phase 3Results posted
- An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary SymptomsCompletedNCT01726270Phase 2Results posted
- Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)CompletedNCT01721876Phase 3Results posted
- Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal ImpairmentCompletedNCT01721837Results posted
- Safety and Efficacy Study of Empagliflozin and Metformin for 24 Weeks in Treatment Naive Patients With Type 2 DiabetesCompletedNCT01719003Phase 3Results posted
- Study to Evaluate the Pharmacokinetics and Pharmacodynamics of Dabigatran Etexilate in Patients With Stable Severe Renal Disease.CompletedNCT01711853Phase 1Results posted
- Nonivamide/Nicoboxil Ointment in Acute Low Back PainCompletedNCT01708915Phase 3Results posted
- Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 PatientsCompletedNCT01708902Phase 3Results posted
- A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes MellitusCompletedNCT01707147Results posted
- Bioequivalence Trial of 2 Dose Strengths of BI 201335 NA Soft Gelatine CapsulesCompletedNCT01704846Phase 1Results posted
- Study to Investigate the Relative Bioavailability, Influence of Pantoprazole Coadministration and Food Effect of Different Oral Formulation of BI 113608CompletedNCT01703858Phase 1Results posted
- A Study to Characterize Pharmacokinetics of Tiotropium + Olodaterol Fixed-dose Combination in Japanese Patients With COPD.CompletedNCT01703845Phase 1Results posted
- Trial to Assess the Influence of 4 Weeks' Treatment With Linagliptin as Compared to Glimepiride and Placebo on Endothelial Function in Patients With Type 2 Diabetes Using FMD (Flow-Mediated Vasodilation)CompletedNCT01703286Phase 1Results posted
- Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller MedicationCompletedNCT01696071Phase 2Results posted
- Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®CompletedNCT01696058Phase 3Results posted
- Co-administration of Olodaterol Respimat® and Tiotropium Handihaler®CompletedNCT01694771Phase 3Results posted
- Investigation of Food Effect and Gastric ph Increase on the Bioavailability of FaldapravirCompletedNCT01694706Phase 1Results posted
- BI 836858 Dose Escalation in Patients With Refractory or Relapsed Acute Myeloid Leukemia and in Patients With AML in Complete Remission With High Risk to RelapseCompletedNCT01690624Phase 1Results posted
- Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BI 655075 Administered Alone or With Dabigatran EtexilateCompletedNCT01688830Phase 1Results posted
- Efficacy, Pharmacokinetics, and Safety of BI 695500 in Patients With Rheumatoid ArthritisTerminatedNCT01682512Phase 3Results posted
- Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 113608 in Healthy Male VolunteersCompletedNCT01681277Phase 1Results posted
- Investigation of Drug-drug Interaction of Nintedanib and Ketoconazole in Healthy Male VolunteersCompletedNCT01679613Phase 1Results posted
- Demonstration of Bioequivalence of Empagliflozin and Metformin Given in One Tablet Compared to the Intake of Single TabletsCompletedNCT01672788Phase 1Results posted
- GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)CompletedNCT01671007Results posted
- Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 1CompletedNCT01663987Phase 4Results posted
- Investigate the Impact of Early Treatment Initiation With Tiotropium in Patients Recovering From Hospitalization for an Acute COPD Exacerbation 2CompletedNCT01662986Phase 4Results posted
- Volasertib in Japanese Patients With Acute Myeloid Leukemia (AML)CompletedNCT01662505Phase 1Results posted
- Long-term Daily Use of Trazenta® Tablets in Patients With Type 2 Diabetes MellitusCompletedNCT01650259Results posted
- A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin TherapyCompletedNCT01649297Phase 2Results posted
- Phase I Trial of Afatinib and Trastuzumab in HER2 Overexpressing Cancer.CompletedNCT01649271Phase 1Results posted
- A Study of Intermittent, High-dose Afatinib to Determine the Maximal Tolerated Dose and Assess Activity of This Dose Against Non-small Cell Lung Cancer With T790M MutationsCompletedNCT01647711Phase 1Results posted
- Assessment of Health-status of Patients With Chronic Obstructive Pulmonary Disease (COPD) on Maintenance Therapy With Spiriva HH Measured by COPD Assessment Test (CAT) TestCompletedNCT01644734Phase 4Results posted
- Drug Interaction Study With BI 201335 and Methadone or Buprenorphine/NaloxoneCompletedNCT01637922Phase 1Results posted
- Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent AsthmaCompletedNCT01634152Phase 3Results posted
- Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent AsthmaCompletedNCT01634139Phase 3Results posted
- Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent AsthmaCompletedNCT01634113Phase 2Results posted
- Drug-interaction Trial in Healthy Subjects With Oral Administration of Empagliflozin (BI 10773), Rifampicin and ProbenecidCompletedNCT01634100Phase 1Results posted
- Extension Trial of the Long Term Safety of BIBF 1120 in Patients With Idiopathic Pulmonary FibrosisCompletedNCT01619085Phase 3Results posted
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306CompletedNCT01611311Phase 1Results posted
- Pharmacokinetics and Safety Study of BI 695502 in Healthy SubjectsCompletedNCT01608087Phase 1Results posted
- Study Evaluating Absorption, Distribution, Metabolism and Excretion (ADME) of Single Dose [14C]-BI 207127 in Healthy Male VolunteersCompletedNCT01605461Phase 1Results posted
- Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With DabigatranCompletedNCT01595854Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of Single Rising Oral Doses of BI 1015550 in Healthy Male VolunteersCompletedNCT01594515Phase 1Results posted
- Dose Escalation Study of Nintedanib (BIBF 1120) in Japanese Patients With Hepatocellular CarcinomaCompletedNCT01594125Phase 1Results posted
- Bioequivalence of Metformin Under Fed Conditions After Administration of Linagliptin / Metformin Fixed Dose Combination Tablet and Single TabletsCompletedNCT01581931Phase 1Results posted
- Safety Tolerability and Pharmacokinetic of BI 411034CompletedNCT01581684Phase 1Results posted
- Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 DiabetesCompletedNCT01581658Phase 1Results posted
- Pharmacokinetics and Safety of BI 201335 in Patients With Mild to Severe Renal ImpairmentCompletedNCT01580306Phase 1Results posted
- Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination TrialCompletedNCT01579474Phase 3Results posted
- Drug-drug Interaction of BI 201335 and MicrogynonCompletedNCT01570244Phase 1Results posted
- Characterization of 24-hour Lung Function Profiles of Inhaled Tiotropium + Olodaterol Fixed Dose Combination in Patients Suffering From Chronic Obstructive Pulmonary DiseaseCompletedNCT01559116Phase 3Results posted
- First in Man Trial of BI 113608CompletedNCT01540825Phase 1Results posted
- Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /MetforminCompletedNCT01540487Phase 1Results posted
- Japan Long-term Safety for Tiotropium Plus OlodaterolCompletedNCT01536262Phase 3Results posted
- Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male VolunteersCompletedNCT01535638Phase 1Results posted
- Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.CompletedNCT01533935Phase 3Results posted
- Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD PatientsCompletedNCT01533922Phase 3Results posted
- This Trial Evaluates Safety, Pharmacokinetic Profile and Anti-viral Response of BI 207127 and BI 201335 for Patients With Chronic Hepatitis CCompletedNCT01528735Phase 2Results posted
- Safety and Efficacy of Long-term Daily Use of Mirapex®-LA Tablets in Patients With Parkinson's DiseaseCompletedNCT01525641Results posted
- Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected PatientsCompletedNCT01525628Phase 1Results posted
- A Study to Determine the Effect of Tiotropium + Olodaterol Fixed Dose Combination on Exercise Endurance Time During Constant Work Rate Cycle Ergometry Test in COPDCompletedNCT01525615Phase 3Results posted
- Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical PracticeCompletedNCT01524900Results posted
- LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based ChemotherapyCompletedNCT01523587Phase 3Results posted
- Linagliptin and Metformin Versus Linagliptin in Newly Diagnosed, Untreated Type 2 DiabetesCompletedNCT01512979Phase 4Results posted
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising DosesCompletedNCT01505894Phase 1Results posted
- Follow on Study From RE-ALIGNTerminatedNCT01505881Phase 2Results posted
- Pharmacokinetics and Safety Study of BI 695501 in Healthy SubjectsCompletedNCT01505491Phase 1Results posted
- Assessment of Exposure of BI 409306 in Cerebrospinal Fluid (CSF) Relative to Plasma as Well as to Evaluation of the Effect of Different Doses of BI 409306 on the cGMP (Cyclic Guanosine Monophosphate) Levels in CSF in Healthy Male VolunteersCompletedNCT01493570Phase 1Results posted
- A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial FibrillationCompletedNCT01493557Phase 4Results posted
- Post-Marketing Surveillance of Prazaxa® on the Long-term Use in Patients With Nonvalvular Atrial FibrillationCompletedNCT01491178Results posted
- Tiotropium (18mcg) in Chronic Obstructive Pulmonary Disease (COPD) Patients With a Respiratory InfectionCompletedNCT01483625Phase 4Results posted
- GLORIA-AF Registry Program - Second and Third PhasesCompletedNCT01468701Results posted
- LUX-Lung 7: A Phase IIb Trial of Afatinib(BIBW2992) Versus Gefitinib for the Treatment of 1st Line EGFR Mutation Positive Adenocarcinoma of the LungCompletedNCT01466660Phase 2Results posted
- Dabigatran Etexilate in Patients With Mechanical Heart ValvesTerminatedNCT01452347Phase 2Results posted
- Investigation of the Effect of Food on the Bioavailability of a 25 mg Empagliflozin Tablet as Well as Assessment of Dose Proportionality Between 10 mg and 25 mg Empagliflozin Tablets Under Fasting Conditions.CompletedNCT01451775Phase 1Results posted
- Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain MetastasesCompletedNCT01441596Phase 2Results posted
- Linagliptin in Combination With Metformin in Treatment Naive Patients With Type 2 Diabetes Mellitus and Insufficient Glycaemic ControlCompletedNCT01438814Phase 4Results posted
- Tiotropium +Olodaterol Fixed Dose Combination (FDC) Versus Tiotropium and Olodaterol in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT01431287Phase 3Results posted